Apolipoprotein B Deficiency

Watchlist
Retrieved
2021-01-18
Source
Trials
Genes
Drugs

Apolipoprotein B deficiency is an autosomal dominant disorder resulting from a missense mutation which reduces the affinity of apoB-100 for the low-density lipoprotein receptor (LDL Receptor). This causes impairments in LDL catabolism, resulting in decreased levels of low-density lipoprotein in the blood. The clinical manifestations are similar to diseases produced by mutations of the LDL receptor, such as familial hypercholesterolemia. Treatment may include, niacin or statin or ezetimibe.:534

It is also known as "normotriglyceridemic hypobetalipoproteinemia".

See also

  • Familial hypercholesterolemia